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ABSTRACT
We report a survey of audience members’ responses
(147 questionnaires collected at seven performances)
and 10 in-depth interviews (ﬁve former patients and two
family members, three medical practitioners) to
bloodlines, a medical performance exploring the
experience of haematopoietic stem-cell transplant as
treatment for acute leukaemia. Performances took place
in 2014 and 2015. The article argues that performances
that are created through interdisciplinary collaboration
can convey otherwise ‘inaccessible’ illness experiences in
ways that audience members with personal experience
recognise as familiar, and ﬁnd emotionally affecting. In
particular such performances are adept at interweaving
‘objectivist’ (objective, medical) and ‘subjectivist’
(subjective, emotional) perspectives of the illness
experience, and indeed, at challenging such distinctions.
We suggest that reﬂecting familiar yet hard-to-articulate
experiences may be beneﬁcial for the ongoing emotional
recovery of people who have survived serious disease,
particularly in relation to the isolation that they
experience during and as a consequence of their
treatment.
INTRODUCTION
This article explores research (designed and imple-
mented by Emma Weitkamp) that tested the cap-
acity of one example of ‘medical performance’
(created through a project led by Alex Mermikides)
to convey a particularly ‘inaccessible’ experience of
illness and medical treatment to people with differ-
ent prior knowledge of this subject matter. Medical
performance will be introduced below as an emer-
ging category of arts practice, which, in some of its
formats, can make a distinctive contribution to cul-
tural understandings of illness and to the ongoing
emotional recovery of people who have survived
serious disease. Moreover, we argue that medical
performances that are created through interdiscip-
linary collaboration are particularly effective in
conveying experiences of serious illness because of
their capacity to challenge polarised distinctions
between ‘objective’ medical knowledge and ‘sub-
jective’ experience.
The value of the arts as a means of exploring
and conveying subjective experiences of illness has
long been recognised, most recently in Bates,
Bleakely and Goodman’s Medicine, Health and the
Arts,1 an important positioning of the arts within
the scope of the medical humanities. Bates et al’s
inclusion of performance within this volume is
unusual and reﬂects a proliferation, and increased
recognition, of performance practices that surround
‘medical systems and bodies’ and which engage
with ‘social and personal realities’ that open up in
relation to these—this is ‘medical performance’ as
deﬁned by cultural scholar Petra Kuppers.2 In our
articulation of the term, medical performance
includes but goes beyond conventional theatre pro-
ductions with medical subject matter (eg, Margret
Edsom’s Wit (1995)), encompassing autobio-
graphical performances of illness (the subject of
this paper); those that incorporate medical practices
into performance (most famously, Orlan’s surgery
performances); as well as the use of performance tech-
niques within medical education (eg, the Performing
Medicine project (http://www.clodensemble.com/
medicine.htm).
In discussing an example of ‘medical perform-
ance’, our research seeks to situate performance
more prominently within the scholarship on arts in
health3 4 and to provide a bridge to performance
scholarship concerned with patient experiences and
medical practices and sciences.5–8 The concerns of
the project discussed in this article also draw upon
scholarship on pathography as a practice that con-
ceptualises illness experiences through the creation
of narratives. Initiated in seminal studies by Frank9
and Charon,10 this ﬁeld remains relevant to discus-
sions of patient experiences and the expression of
these through various art forms ranging from the
graphic novel11 to performance.12 Indeed, a recent
chapter by performance scholar Brodzinski13 posits
performance created by ‘patient-performers’ as a
way of actualising Frank’s emphasis on embodi-
ment—stories ‘told not just about the body but
through it’ (2016, p. 3) by literally putting the
body of the patient centre stage. More broadly, this
article pertains to the ongoing project to problem-
atise what Nettleton summarises as the ‘biomedical
model’ of illness,14 a project founded by Foucault’s
seminal study of ‘the clinic’,15 which has been
taken up, in various ways, within cultural studies,16
sociology17 18 and anthropology.19 20 A text that
was particularly inﬂuential upon the medical per-
formance explored in this paper is Jackie Stacey’s
Teratologies: a cultural study of cancer,21 which
draws upon all these ﬁelds of scholarship in order
to navigate personal, social and cultural meanings
of this illness.
BACKGROUND
An ‘inaccessible’ experience of illness
Bloodlines seeks to convey a patient’s experience of
acute lymphoblastic leukaemia (ALL) and its treat-
ment through haematopoietic stem-cell transplant
(HSCT). ALL is a particularly aggressive cancer of
the white blood cells with poor prognostic
outcome in adults. In his biography of cancer,
Murkharjee describes ALL as ‘cancer in one of its
most explosive, violent incarnations…terrifying to
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experience, terrifying to observe, and terrifying to treat’.22 For
some patients the best chance of survival and possible cure is an
HSCT.i However, this treatment is only available to those for
whom a compatible donor can be found and who are strong
enough to withstand the preparatory regime, which is itself
‘potentially lethal’.23 Nevertheless, since the mid-1990s HSCT
has become a viable treatment option and research has focused
on survival rates, and quality-of-life issues for transplant recipi-
ents and survivors.24
A study on the psychosocial experience of patients very
recently diagnosed with acute leukaemia25 describes the ‘exist-
ential crisis’ of being suddenly faced with the immediate threat
of death. This is exacerbated by immediate hospitalisation, the
rush to undergo often invasive diagnostic tests (eg, bone
marrow biopsies and lumbar punctures) and confrontation with
unfamiliar medical terminology. A core category emerging from
this study was ‘uncertainty’: why me? Will I survive?’ A study of
patients undergoing HSCT25 suggests that this uncertainty
intensiﬁes as therapy involves the constant evaluation and
careful balancing of disease-related and treatment-related risks,
with the threat of mortality ever present. A recent doctoral
paper on the experience of HSCT summarises it as a ‘severe dis-
ruption…in terms of their physical, psychosocial and emotional
being and their everyday lives’ (E Dunn. Safe in the Bubble, Out
into the Unknown: returning home following allogeneic stem
cell transplantation. PhD thesis submitted to University of
Surrey, September 2014. http://epubs.surrey.ac.uk/808305/).
This study also foregrounds isolation as an important consid-
eration, both because limits on visitors (to protect the patient
during periods of immunosuppression) curtails the emotional
support of family and friends, and in the sense of undergoing
an experience that others do not understand. A particularly iso-
lating aspect of this illness/treatment experience is that it seems
to exceed established ways of conceptualising the body and
mind. Transplant survivor and psychologist Ron Morstyn26
describes his own struggle to access and explain the experience,
how it necessitated a profound shift in his sense of himself as an
embodied being. This shift could not be encompassed by the
perspectives that he encountered during his treatment: what
he called ‘objectivist’ (exclusive focus on physical symptoms of
the medical profession) nor ‘subjectivist’ (an equally inadequate
exclusive focus on emotion and subjectivity) perspectives. The
creators of bloodlines posited that a performance created
through a process of interdisciplinary collaboration and a dra-
matic form that layered and interwove different perspectives
and art forms would enable them to blend these perspectives
and thereby capture at least some aspects of this illness
experience.
Bloodlines: blending ‘objectivist’ and ‘subjectivist’
perspectives
Bloodlines is the product of a practical research project sup-
ported by the Arts and Humanities Research Council under the
Science in Culture theme, led by Alex Mermikides, that
explored devising as a methodology for creating medical perfor-
mances. Devising is a form of performance-making that favours
collaboration—in this case interdisciplinary collaboration—as a
means of exploring diverse perspectives on a subject and creat-
ing alternative forms and narratives.27–29 The creative team of
bloodlines represented a range of personal and disciplinary
perspectives, including a survivor of ALL (composer, Milton
Mermikides), his sibling stem-cell donor (director, Alex
Mermikides) and clinical haematologist (Ann Van de Velde).
Also involved in the project were a choreographer, dancers and
a digital artist specialising in science communication.
The performance that resulted from this collaboration
includes two interwoven strands. One follows the experiences
of a patient (performed by dancer/choreographer Adam
Kirkham) through the treatment protocol for ALL with scenes
on phases of chemotherapy, total body radiation that lead to a
neutropenic state, and the transplant itself. The other is a series
of medical lectures, performed initially by Ann Van de Velde,
and in later performances, Dr Rebecca Law (a doctor-turned
actor) on healthy and pathological blood formation, histocom-
patibility for transplant and the process of apheresis (harvesting
of stem cells from the donor, performed by dancer Viv Rocha).
The 30 min piece becomes increasingly abstract as treatment
intensiﬁes, the doctor’s voice increasingly disembodied, and the
two strands progressively more interwoven. Through this the
‘medical’ and the ‘personal’ perspectives are layered and
blurred.
A key example of this ‘blending’ is a scene on histocompatibi-
lity for transplant. The scene opens with a snippet of lecture
presented directly to the audience by the doctor, outlining the
risks of transplant and the need for ‘matched’ donors. She is
replaced by the patient, who then takes his place on a bed pro-
jected onto the back wall of the stage (see ﬁgure 1). A ﬁlmed
image of the same dancer (wearing jeans rather than the charac-
teristic jogging trousers of the patient) rolls onto the bed and
there begins a duet between the live and ﬁlmed version of the
patient, with a choreography involving a series of matched and
mismatched postures and gestures. The quality of the movement
is unadorned and repetitive, akin to movements one might
enact during a medical examination and thereby suggestive,
perhaps, of the patient’s compliance with treatment. This
dynamic is reinforced by the doctor’s words, which now return
as live voice-over, enumerating statistical probabilities of donor–
recipient matches.
One reason that dance was a chosen form within this per-
formance is its openness to interpretation. For example, the pro-
jected images of the patient in this scene might represent a
series of would-be donors that are being assessed as potential
matches; or the patient as his former healthy self and, with this,
a hoped-for return to health; or as a hallucinated companion
who might counter his loneliness. The range of potential mean-
ings is contained to some degree by the doctor’s text, yet indi-
vidual audience members might attribute their own meanings to
the scene and, for some, recognise aspects of their own experi-
ences in it.
Performances
Bloodlines was performed in arts, academic, medical and science
settings in the UK and Belgium, attracting audiences with a
range of personal and professional relationships to the medical
subject matter. Each performance included a postshow ‘Q&A’
discussion with the creative team (sometimes with additional
guests) and some were preceded by introductory talks by team
members and/or invited specialist speakers. A summary of the
performances discussed in this article is provided in table 1.
AUDIENCE RESEARCH
Research design
Audience research was designed by Emma Weitkamp, who was
not involved in the creation of bloodlines itself, but was invited
iAlso known as bone marrow transplant although the two procedures
differ in the harvesting process.
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by the team after the performance had been devised to explore
its impact on audiences. The research uses a mixed method
design comprising two elements: a short questionnaire distribu-
ted to and completed by audience members immediately after
the performance, and a series of in-depth semistructured inter-
views with select audience members that took place at least a
week after the performance.
The survey element of the research design was developed
through the creation of a postshow questionnaire that com-
prised primarily open questions. This self-administered ques-
tionnaire was designed to explore themes emerging that related
to the communication of information about HSCT and the sub-
jective experience of the patient. The survey was administered at
a developmental performance of bloodlines held at the Dana
Centre, Science Museum, London, UK. Responses to this ques-
tionnaire (n=29), together with ﬁve interviews with members
of the audience (including those with medical, personal and no
prior experience of HSCT), were used to construct a range of
questions to explore whether the performance communicates
both the ‘objectivist’ and ‘subjectivist’ experience of HSCT.
These were discussed within the performance development
team (which comprised a range of experiences of HSCT) and
revised to reﬂect their collective experience. The same approach
was used to construct the questions used to categorise the audi-
ence member’s experiences of HSCT. This yielded a pilot ques-
tionnaire comprising likert-like scale questions, which were
always followed by an invitation to provide additional com-
ments and one question inviting respondents to select three
words that expressed their feelings about the performance (this
question was useful for us to gauge responses to the perform-
ance at this early stage, but was not included in the ﬁnal ques-
tionnaire as it did not address the aims of the survey directly
and to enable a shorter questionnaire that could be handed to
audience members as they left the performance). Twenty com-
pleted pilot questionnaires were analysed for clarity of question
wording as well as to ensure that each question produced a
spread of responses.
The ﬁnal questionnaire comprised closed and open questions
to gather data on audience background, and their perspectives
on the performance. In terms of background, respondents were
asked about their previous experience of HSCT: professional
experience (eg, medical practitioner or afﬁliated to a registry),
personal experience (eg, as a transplant recipient, donor or
known to a recipient or donor) or as having no previous knowl-
edge or experience (an option was also provided for those pre-
ferring not to reveal this information). Closed questions relating
to the performance were designed to explore the balance
between ‘objectivist’ and ‘subjectivist’ aspects, asking whether it
communicated information about the subject matter and
increased their understanding of HSCT, as well as exploring the
extent to which it conveyed the subjective experience of the
patient. Open questions invited the audience to elaborate on
these views. The questionnaire also sought to explore general
attitudes towards theatre as a means of communicating medical
information. One hundred and forty-seven questionnaires were
received from seven performances in a range of venues (see
table 1). Questionnaire data were analysed using SPSS, V.22.
Where cell sizes allowed, Pearson’s chi-squared tests have been
used to test statistical differences between audience members
having professional, personal or no previous experience of
HSCT.
A set of questionnaires collected from medical professionals
attending the Belgian Haematological Society Conference
(BHC) were subjected to additional analysis. As English is
unlikely to be the ﬁrst language of this audience, we explored
whether those completing the questionnaire were more or less
likely to provide open comments as one way to assess the
impact of language. Participants from the BHC were slightly less
likely to make open responses than other groups (39%; n=17
BHC respondents made open comments, compared with 67%
(n=14) of people with personal experience and 47% (n=23) of
people with no experience), suggesting that the language of the
questionnaire might have reduced willingness to provide open
comments (though this could equally be related to professional
Figure 1 Bloodlines performance
photo by Anna Tanczos.
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role). However, it should be noted that the open comments
received from this group were of similar length and covered
similar topics/issues as those found in the other groups.
Qualitative data were collected via in-depth, semistructured
interviews with patients (5), family members (2) and healthcare
professionals (3) lasting from 15 to 45 min. Interviews explored
respondents’ views on both the objective (medical) and subject-
ive (experiential) content of the performance, the impact of the
performance on the respondent (eg, in terms of how they think
about their own personal or professional experience of trans-
plant) and their views and experience of medical performance
more generally. Interviews were carried out in English and it
should be noted that English was not the ﬁrst language of the
eight interviewees who attended the performance at UZA.
These interviewees were recruited via an email sent out to all
audience members by Ann Van de Velde. They were informed in
the email that the interviews would be conducted in English,
and this is likely to have inﬂuenced the choice to participate,
with only those more conﬁdent in English agreeing. During the
interview process itself, care was taken to ensure that partici-
pants could clarify questions and have time to formulate their
response. The interviewer also took time to clarify any answers
that were unclear or ambiguous. While clearly these interviews
were conducted in a second language, the individuals opting to
participate spoke with ease during the interviews and did not
seem to struggle to convey their ideas. Interviews were con-
ducted by a research assistant or Emma Weitkamp via Skype or
phone. None of these interviewees had previously attended a
performance about a healthcare or medical issue, noting that
they had not had the opportunity to do so before.
All interviews were ﬁrst transcribed and then analysed themat-
ically.30–32 This approach was chosen to enable the researchers
to focus on key topics of relevance to the study, while generat-
ing rich data and allowing themes to emerge empirically from
the data rather than being constrained through predetermined
survey categories. Themes emerged during repeated reading of
transcripts. Although Emma Weitkamp coded the interviews,
preliminary codes and emerging themes were discussed and
reﬂected on with Alex Mermikides to provide a wider perspec-
tive on the emerging ﬁndings and enhance the quality of the
analysis. As Alex Mermikides has personal experience of HSCT,
we felt that it was important that this in-depth knowledge was
brought to the analysis and interpretation of the qualitative
data. Any issues arising during analysis and coding (eg, in rela-
tion to interpretation of meaning) were discussed and agreed
between the authors. The small number of interviews and
exploratory nature of the study meant that immersing both
authors in the interpretation of the data was more appropriate
than sample coding followed by intercoder reliability checks.
Findings reported here focus on emergent themes relating to
reﬂection of interviewees’ experiences (subjective and objective),
responses to objectivist and subjectivist content of the perform-
ance, impact on the interviewee and potential inﬂuence on
medical practice.
Ethical considerations
Ethical considerations associated with the performance itself
relate to its autobiographical nature (which might lead to identi-
ﬁcation of former patients) and to the potential distress of audi-
ence members that may result from exposure to an emotive
subject matter. The abstract nature of the performance ensured
that no actual patients or medical professionals could be recog-
nised. However, the patients upon whose experiences the per-
formance was based (the director and the composer) were
identiﬁable in publicity and through their participation in
accompanying events. In both cases, the decision to forgo ano-
nymity was made willingly by both parties. To mitigate against
causing unacceptable levels of distress among audience members
due to the emotive nature of the subject, the topic of the per-
formance was clearly declared in advance publicity and attend-
ance to the event was always voluntary (and in all but one case,
free of charge). In the analysis below we mention one example
of a transplant survivor who chose not to attend the perform-
ance because of the potential for emotional distress. For those
who did attend, postshow discussions (which included partici-
pation by Milton Mermikides, himself a cancer and transplant
Table 1 Performance details
Venue Audience approx number/type Accompanying events Data collected
Rose Theatre (2014), Kingston 30/General* Postshow discussion with creative team Questionnaires: 20
Royal Central School of Speech
and Drama (2014)
80/Performance researchers and students Postshow discussion with creative team Questionnaires: 16
Antwerp University Hospital
(UZA; 2014)
Event celebrating 30 years of
transplant at UZA
180/Transplant survivors and their
families. Staff from UZA
Film of performance shown to 20 medical
staff unable to attend performance
Introductions by UZA staff; presentations by two
transplant survivors
Introduction by Ann Van de Velde, postshow discussion
with Alex Mermikides (director) and Kirkham
Questionnaires were not
distributed
Interviews with five patients,
two partners, one nurse
Belgian Haematological Society
Conference (2015)
200/Specialist nurses Part of conference programme. Introduction by
Ann Van de Velde. Postshow discussion with creative
team
Questionnaires: 44
Ivy Centre (2015), Guildford
University of Surrey
30/General Preshow talks by blood cancer nurse; theatre
professionals (director and composer)
Postshow discussion with creative team
Questionnaires: 18
Interviews with two healthcare
professionals
Rose Theatre (2015) Kingston
Connections Festival
40/General Postshow discussion with creative team Questionnaires: 20
Clapham Omnibus (2015) Inside
Out Festival
20/General Postshow discussion with creative team and bone
marrow registry representative
Questionnaires: 4
John Thaw Theatre (2015)
Manchester Science Festival
40/General Preshow talks by director and composer
Postshow discussion with Cancer Research UK
representative and creative team
Questionnaires: 25
*Performances listed as ‘general’ were advertised to the general public. Audience members may have included people with professional or personal experience of haematological cancer
or HSCT. Other events were not advertised beyond the stated communities.
HSCT, haematopoietic stem-cell transplant.
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survivor) provided an opportunity to reﬂect on and express
emotions provoked by the performance within a supportive
context.
This same concern not to cause unnecessary levels of distress
among audience members who might have negative personal
experience relating to the subject matter was raised by the audi-
ence surveys. Participation in surveys was voluntary and those
ﬁlling in questionnaires or consenting to participate in inter-
views were warned during consent-taking that they would be
asked to declare personal experience of cancer and/or HSCT.
Ethical approval for the research was provided by Kingston
University Research Ethics Committee (1516CHA4).
Audience characteristics
The audience comprised 34% (n=50) healthcare professionals,
14% (n=21) with personal experience, 33% (n=49) with no
previous experience of HSCT, 12% (n=18) indicated ‘other’
(which comprised a range of experience including studying
biology at school or university) and >1% (n=1) who preferred
not to say (there were also eight missing responses). Thirty-eight
percent (n=56) had previously attended a performance about
medical or scientiﬁc topics, while 59% (n=86) had not (3%,
n=5, missing responses). There was no statistical difference
between audience groups (professional, personal, no experience
or other) and whether they had previously attended a medical
or scientiﬁcally themed performance (χ2 (4, N=139)=4.1;
p=0.35), suggesting that the groups can be considered equally
(un)familiar with the genre. As anticipated, venue did inﬂuence
the backgrounds of the audience (one performance was given at
the Belgian Haematological Society meeting, where 76%
(n=38) of respondents indicating professional experience were
recruited). Three of the seven performances attracted no respon-
dents with professional experience.
Overview of responses
Respondents overwhelmingly felt that the performance of
bloodlines communicated information about stem-cell trans-
plantation in an interesting and effective way (99% strongly
agree/agree, n=145; two people either disagreed or neither
agreed nor disagreed)ii and that it conveyed the subjective
experience of someone facing a serious disease or undergoing
treatment (93%, n=136 strongly agreed or agreed; 5% neither
agreed nor disagreed (n=8) and 2% (n=3) disagreed or strongly
disagreed). The overlap between these ﬁgures suggests that the
performance was able to blend both the subjectivist and object-
ivist perspectives in a way that was relevant to the audience.
While all respondents who provided information about
their past experience of HSCT agreed or strongly agreed with
the statement ‘the performance communicated information
relating to stem cell transplant in an interesting and effective
way’, there was a statistically signiﬁcant difference between
groups (χ2 (3, n=138)=14.4; p<0.005); those with personal
experience or no previous knowledge were more likely to
strongly agree with the statement. A similar trend is also appar-
ent in relation to communication of the subjective experience of
HSCT (ﬁgure 2).
Although more mixed, a large majority of the respondents
also felt that the performance increased their understanding of
the importance of matching a donor and a recipient of HSCT
transplant (82%, n=120 strongly agree/agree; 14%, n=20
neither agree nor disagree; and 3%, n=5 strongly disagree/dis-
agree). There is a trend for those with professional experience
to indicate less agreement with the statement, which is not
unexpected (and noted by some in the free text with comments
such as ‘only because I know it already’, MSF25).
Respondents were asked to indicate their agreement (on a
ﬁve-point Likert-like scale, 1=Strongly agree) with four state-
ments about medical performances in general. Audience
members strongly agreed that performance can make medical
science relevant (median=1.0) and agreed that medical science
should be portrayed accurately in such performances
(median=2.0). Audience members were neutral (median=3)
about the importance of artistic quality and disagreed with the
statement that ‘engaging performance pieces rarely help
the audience understand science/medical topics’ (median=4).
The data suggest a trend for those with no experience to be
more likely to respond neutrally to the statement ‘medical
science should be portrayed accurately in performance pieces’
(ﬁgure 3).
TRANSPLANT SURVIVORS
Summary of comments
All of the transplant patients interviewed (ﬁve) indicated that
the performance reﬂected their own experience in many ways,
particularly in relation to how they felt physically and emotion-
ally as they went through diagnosis and treatment (and to an
extent still feel). As interviewee 4 states “It captured how you
Figure 2 The performance
communicated the subjective
experience of someone facing a serious
disease and undergoing treatment.
iiNb. the two people who did not agree with the statement also did not
provide details of their past experience of HSCT, so are not included in
ﬁgure 2.
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felt in that moment and it brought it back to life.” This led to
complex emotions for some audience members, who found that
the performance brought back feelings they did not necessarily
want to remember, though this was still perceived as a positive
experience. As interviewee 2, who received his transplant just
11 months before seeing the show, explains: “A lot of feelings
came back. Also a lot of feelings that I … do not want to
remember. But it was OK. It gave me lots of emotions inside.”
Responding to the ﬁnal scene (a duet based on the post-
transplant period when patients are at risk of a serious compli-
cation, graft-versus-host disease, in which donated cells attack
those of the patient), one patient highlighted how the perform-
ance reﬂected physical processes: “The transplantation, the
dance between the two bodies […]. That was a true reﬂection of
the battle between the new stem cells” (interviewee 5 who
experienced graft-versus-host disease). Interviewee 7 pointed
out that she had learned new medical information from the per-
formance, which she did not remember hearing before, refer-
ring to the ‘matching’ scene described above: “I got information
from the play, for example about the HLA types, which I didn’t
get from my own doctor.” HLA (human leucocyte antigen) is
the primary means used to match donors for transplantation.
Patient interviewees all commented that the performance con-
veyed the sense of the patient being alone, in hospital and going
through a very traumatic experience. Interviewee 7 states: “for
me, the message as a patient, was really that it’s a hard time. It’s
very hard and you will be alone … but afterwards it’s all worth
it.” However, the performance also gave patients a sense that
while they had been alone when going through treatment,
others shared a similar experience and this was valued. As inter-
viewee 5 explains: “There were many similarities [with my
experience], processing the news, being alone, the ﬁght to be
alive, to believing. That’s for me the feeling that bloodlines gave
me—that I’m not alone with my situation.” Performing to
patients whose transplant had taken place at the same hospital
provided an additional sense of ‘togetherness’. As interviewee 2
notes “I didn’t mind to remember all those things because it was
being together with a lot of friends, although I didn’t know the
people.”
Most of the patients also mentioned that the performance
highlighted for them how far they had come since their trans-
plant. However, patients have to be ready to experience this
type of event and to reﬂect on their experience in this way.
Interviewee 6 notes about her husband, who was the transplant
recipient, “he was not ill enough or cured enough to be open to
an artistic evening.” She goes on to suggest that this type of per-
formance might be helpful to people before they have a trans-
plant, as preparation so that “you can visualise what will happen
in your body.” A theme that was picked up by other intervie-
wees, “it really gives an image of what you can expect—the bad
things you have to go through ﬁrst and then the good things to
follow, but also, the warning for the risks that are concerned
with [transplantation].”iii
Unprompted open comments on the questionnaire from those
indicating personal experience of transplantation support these
themes to an extent. For example, several respondents indicated
learning something new, such as “I did not realise that donors
could be unrelated—it was my understanding that it was not
statistically viable for donors to be unrelated” (CSSD3) and ‘the
1023 revelation’ (MSF2). Both of these comments refer to the
challenge of ﬁnding a match with an unrelated donor (identiﬁed
through registries such as the Anthony Nolan Trust or Delete
Blood Cancer in the UK). The ﬁrst comment is surprising given
the efforts of these registries to advertise the need for potential
donors to come forward for unrelated patients, though, as the
‘revelation’ suggests, the probability of a match in these cases is
small.
Other open responses focused on the emotional engagement
engendered by the performance such as “I found it very moving
due to personal experience, and dealt with the emotions around
diagnosis and treatment in an engaging and accurate and
Figure 3 Medical science should be
portrayed accurately in performance
pieces.
iiiExtracts of bloodlines have already been used in this context (eg, at the
Patients Information Day at St. Georges Hospital in London) and
informal responses in that context were positive. However, the creative
team feel that some adaptations would need to be made before a
full-length performance be employed in this way.
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emotive way” (Ivy4) and “the performance and information
made me feel as well as think” (Ivy9).
Beneﬁts to transplant survivors and beyond
The interview results suggest that the performance can provide
a powerful cathartic experience for survivors of HSCT, for
whom ongoing negative sequelae can include ‘inability to
resume social roles, sleep disturbance, infertility issues and phys-
ical and emotional distress […] post-traumatic stress disorder
and/or mood disorders, including anxiety and depression’
(Beeken et al, p. 153).33 While watching a single performance is
unlikely to address all these issues, the experience of reliving a
negative experience within a safe and shared environment
appears to have had a beneﬁcial effect in terms of the emotional
aspects, at least in the short term. The potential for longer-term
beneﬁts for transplant survivors is as yet untested, but one way
in which the performance might bring these about is by encour-
aging patients to further reﬂect on their experiences with family
members. As interviewee 4 explains,
“[…] it’s often very hard to speak about that [experience of
transplantation], about those emotions. So in that way, I can
imagine that it can be a helpful tool to make a ﬁrst step in talking
about it. … not all patients are open about their emotions when
they go through such things.”
Other interviewees explained how the performance would help
family members understand what was happening to the patient,
“I think that with this performance, the family of the patient
will better understand how the medication changes the patient’s
behaviour” (interviewee 5).
Moreover, there are also indications that the capacity of the
performance to convey the subjective experience of the patient
may also be beneﬁcial to professionals involved in their care.
Three interviews were conducted with healthcare professionals in
haematology (1) and other areas (2) to explore their views of the
performance and its relevance to healthcare practice. The inter-
viewees highlighted that the performance made them stop and
think about their patients in new ways and encouraged them to
reﬂect on their practice. Interviewee 8 (haematology nurse) felt
that sometimes work got in the way of stopping to consider the
patient as an individual rather than a medical case. As she
explained, “some of them [doctors], I think, don’t really see or
feel or know what it is like [to be a patient].” Respondents to the
questionnaire with healthcare backgrounds also highlighted this
point “It helps us understand the patient’s emotions” (BHC8).
Interviewee 9 (orthopaedic nurse) was struck by the similarities
between the performance and many of her patients who can
become very attached to small medical details, like blood counts:
“patients start to attach too much importance to insigniﬁcant
changes. And I think it’s very difﬁcult to manage their responses
to that.” In a sense, her response was similar to the patients who
felt less ‘alone’ when they shared the experience of watching the
performance with other patients as she reported “it also made
me think ‘it’s not just my patients’.”
Additional comments from medical practitioners within post-
show discussions or in informal conversations with members of
the creative team draw attention to potential changes in medical
practices that might beneﬁt patients. For example, the postshow
discussion at BHC included a lively conversation, prompted by
an audience member’s question on how nurses might support
patients and families. This in turn provoked ideas such as subtle
shifts in how medical procedures and therapies (which can be
perceived as—and indeed are—invasive, toxic and threatening)
are initially proposed to patients and improved internet34 and
phone access for patients in isolation. The theme of isolation
emerged repeatedly. For example, in the postshow discussion
following a ﬁlm screening of the performance for medical pro-
fessionals at UZA, a senior clinician commented that, although
having only one doctor in the performance was unrealistic, it
added to his realisation of just how isolated patients are. Two
nurses commented in an informal conversation following the
performance at BHC that the performance had made them
aware of how often patients are left alone and how distressing
this might be, especially for child patients (eg, when undergoing
radiotherapy). The capacity for the performance to encourage
medical staff to reﬂect on their own patients and to look afresh
at patient care suggests that the performance might contribute
to medical and nurse education or continuing professional
development, and indeed the bloodlines team have subsequently
run workshops with trainee doctors and pathologists in major
London teaching hospitals as part of the Performing Medicine
project. Data from these and future activities, which will allow
this aspect to be explored further.
CONCLUDING REMARKS
Medical performances such as bloodlines seem to offer a
number of beneﬁts for different audience groups. They can
provide survivors of life-threatening illnesses with the opportun-
ity to revisit and (re)conceptualise their traumatic experience.
Through attending such performances, patients may develop a
sense that they ‘are not alone’ in their experience, which might
be heightened if the performance is attended with other patients
(as was the case at UZA). The performance also seems to have
the capacity to help those with no personal experience of trans-
plantation to ‘see or feel or know what it is like’. This may
empower caregivers (family members as well as healthcare pro-
fessionals) to better understand the experience and thereby
empathise and support them through and beyond treatment. It
might also encourage support of relevant charities by the
general public.
A key factor enabling performance to bring about these bene-
ﬁts lies in its ability to capture illness/treatment experiences in a
way that patients recognise, that feels familiar. This sense of
familiarity may extend to medical professionals. For example,
the cancer expert participating in the postshow discussion at
MSF reported being struck by ‘how familiar it feels, even though
it’s dance’. Indeed, an interesting observation is that the familiar-
ity of the depicted experience tended to centre on scenes that
are relatively abstract: the ‘matching’ scene described earlier, or
one in which the experience of neutropenia (a particularly
immunologically and emotionally vulnerable period) is explored
through a solo dance to the sound of white noise and against a
back-drop of static. One survivor at the UZA performance (now
a support worker at the same hospital) described this scene to
the director as ‘this is exactly how that felt’. Thus, the question
of ‘accuracy’, raised by our survey in relation to medical science,
could usefully be extended to the subjective aspect. Indeed, our
study highlights the value of performance forms that blend mul-
tiple disciplinary and personal experiences of a medical subject
matter, which interweave and ultimately blur the ‘objectivist’
and ‘subjectivist’ perspectives in a way that can capture other-
wise ‘inaccessible’ illness experiences: as one respondent sug-
gested, that “made me feel as well as think” (Ivy9).
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